3D CoSeedis™ in chip Assays – a new 3D cell culture concept for more predictive preclinical drug discovery

The 3D CoSeedis™ technology from abc biopply allows a unique new concept to grow, test and analyze 3D cell cultures. In particular, 3D CoSeedis™ in chip assays show the following benefits:
  • Hundreds of 3D cultures can be aggregated, grown and exposed to drugs simultaneously under identical conditions
  • Hundreds of 3D cultures can be analyzed simultaneously in specially designed assays:
    • no manipulation of individual 3D cultures
    • fixed positions in x, y and z for automated microscopy
    • hands-free, automated assays eliminate culture damage or loss
  • High number of biological replicates results in statistically highly relevant data points
  • Simultaneous signal accumulation of hundreds of 3D cultures renders outliers irrelevant
  • Highly reliable, predictive and robust

Currently available 3D CoSeedis™ in chip Assays:


  • 3D CoSeedis™ Apoptosis in chip Assay
  • 3D CoSeedis™ Co-Culture Assay
  • 3D CoSeedis™ Cytotoxicity in chip Assay
  • 3D CoSeedis™ Dose Response Assay
  • 3D CoSeedis™ Drug Efficacy Assay
  • 3D CoSeedis™ Tumor Relapse Assay
  • 3D CoSeedis™ Histology Assay
  • 3D CoSeedis™ Standard Assay
  • 3D CoSeedis™ Live Cell Detection in chip Assay
  • 3D CoSeedis™ Antibody Penetration Assay
  • 3D CoSeedis™ Late Stage Cancer Relapse Assay
Main Features:
  • in chip: more predictive, reliable and robust
  • in house: integral part of abc biopply’s CRO 3D culture services
  • in licensing: integrate 3D CoSeedis™ in chip assays in your application at your facility

   Best regards

   Marco Leu, PhD
   Sales & Operation
   abc biopply ag

   Direct Email / Phone +41 (0)79 834 95 56

Back to overview

Contact us